Archive for November, 2005
China Regulates Commissioned Drug Processing for Foreign Clients (Asia Pulse via Yahoo! Asia News)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsBEIJING, Dec 1 Asia Pulse - China’s State Food and Drug Administration has recently issued new rules regarding the management of record filing for accepting foreign orders for drug process on a commissioned basis, which will come into effect as of January 1, 2006.
Teva wins tentative approval of insomnia treatment (Reuters via Yahoo! Asia News)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsCHICAGO (Reuters) - Teva Pharmaceutical Industries Ltd. on Wednesday said it won tentative approval from the U.S. Food and Drug Administration to sell 5 mg and 10 mg Zaleplon Capsules, a short-term treatment for insomnia.
FDA approves Novartis’ Trileptal as adjunctive therapy in children (PharmaBiz)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsNovartis Pharmaceuticals Corporation has received an approval from the US Food and Drug Administration for Trileptal (oxcarbazepine) tablets and oral suspension as adjunctive therapy (use in combination with other antiepileptic drugs) in the treatment of partial seizures in children as young as two-years old with epilepsy.
US FDA issues approvable letter to Roche, Trimeris for use of Fuzeon (PharmaBiz)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsRoche and Trimeris have received an approvable letter from the US Food and Drug Administration, in response to their request for inclusion of information about the Biojector 2000 (B2000) needle-free injection device in the Fuzeon (enfuvirtide) labelling.
Mylan receives final FDA approval for glimepiride tabs (PharmaBiz)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsMylan Pharmaceuticals Inc. has received final approval from the US Food and Drug Administration for its abbreviated new drug application (ANDA) for glimepiride tablets, 1 mg, 2 mg, and 4 mg.
Abortion drugs linked to rare fatal infection (RedNova)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsBy Karla GaleNEW YORK (Reuters Health) - Since the US Food and Drug Administration approved mifepristone and misoprostol as abortion-inducing drugs in 2000, there have been four deaths due to profound shock caused by a bacterium called Clostridium sordellii, investigators report.With this type of “medical abortion,” patients are instructed to swallow a mifepristone pill and then a day or two
Older antipsychotics may be riskier in the elderly (RedNova)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsBy Karla Gale NEW YORK (Reuters Health) - In April, the US Food and Drug Administration issued an advisory that the use of atypical antipsychotics increases mortality in elderly persons with dementia, but now investigators report that conventional antipsychotic medications may be even more dangerous. “If confirmed,” Dr.
India Tops The List Of Rejected Food And Drug Exports (Asia Pulse via Yahoo! Australia & NZ News)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsIndia has topped the list for rejected food and drug export consignments to the US, Rajya Sabha was informed on Wednesday.
INDIA TOPS THE LIST OF REJECTED FOOD AND DRUG EXPORTS (Asia Pulse via Yahoo! Australia & NZ Finance)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsHealth / Pharmaceuticals India has topped the list for rejected food and drug export consignments to the US, Rajya Sabha was informed on Wednesday.
FDA halts company production of drugs (UPI)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsWASHINGTON, Nov. 30 (UPI) — The Food and Drug Administration is warning consumers of eye drops and pain relievers made by MBI or Molecular Biologics to stop using the products.
RU486: Don’t go there - On Line opinion
Closed Published by Administrator November 30th, 2005 in Google FDA News, Regulatory AffairsRU486: Don’t go thereOn Line opinion, Australia - 55 minutes ago… In women of childbearing age lethal infections caused by C. sordellii were rare prior to the Food and Drug Administration’s approval of RU486. … Debating the ‘aborti…
RU486: Don’t go there - On Line opinion
Closed Published by Administrator November 30th, 2005 in Google FDA News, Regulatory AffairsRU486: Don’t go thereOn Line opinion, Australia - 14 hours ago… In women of childbearing age lethal infections caused by C. sordellii were rare prior to the Food and Drug Administration’s approval of RU486. …
Older antipsychotics may be riskier in the elderly (Reuters via Yahoo! News)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsIn April, the US Food and Drug Administration issued an advisory that the use of atypical antipsychotics increases mortality in elderly persons with dementia, but now investigators report that conventional antipsychotic medications may be even more dangerous.
Abortion drugs linked to rare fatal infection (Reuters via Yahoo! News)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsSince the US Food and Drug Administration approved mifepristone and misoprostol as abortion-inducing drugs in 2000, there have been four deaths due to profound shock caused by a bacterium called Clostridium sordellii, investigators report.
FDA Tentatively OKs Teva Insomnia Drug - MSN Money
Closed Published by Administrator November 30th, 2005 in Google FDA News, Regulatory AffairsFDA Tentatively OKs Teva Insomnia DrugMSN Money - 2 hours agoNEW YORK (AP) - Teva Pharmaceutical Industries said on Wednesday it received tentative approval from the Food and Drug Administration to sell its 5 milligram … Teva Announces Tentativ…
Search
About
You are currently browsing the Regulatory Affairs Syndicator weblog archives for November, 2005.
Longer entries are truncated. Click the headline of an entry to read it in its entirety.Archives
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- March 2009
- December 2008
- November 2008
- October 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 2005
- November 2005
- October 2005
- September 2005
- August 2005
- July 2005
- May 2005
- January 2005
- December 1969
Categories
- AAPS PharmSciTech (1)
- AIDS Alert (1)
- Am J Cardiol (1)
- Am J Hosp Pharm (1)
- Am Pharm (1)
- Ann Intern Med (1)
- Ann Pharmacother (2)
- Ann Thorac Surg (1)
- Behav Brain Res (1)
- Biomed Instrum Technol (1)
- Can J Cardiol (1)
- Circulation (1)
- Clin Chem (1)
- Compend Contin Educ Dent (1)
- Congest Heart Fail (1)
- Conn Med (1)
- Consumers (2)
- Contracept Technol Update (1)
- Curr Concepts Hosp Pharm Manage (1)
- Curr Urol Rep (1)
- Dentomaxillofac Radiol (1)
- Drug Intell Clin Pharm (1)
- Expert Rev Med Devices (1)
- FDA Consum (1)
- Fed Regist (8)
- Food Drug Law J (2)
- Food Safety (188)
- Google FDA News (14993)
- Health Devices (2)
- Healthc Hazard Mater Manage (2)
- Heart Rhythm (1)
- Home Healthc Nurse (1)
- Hosp Mater Manage Q (1)
- Hosp Technol Ser (1)
- Hospitals (1)
- Int J Health Serv (1)
- Int J Trauma Nurs (1)
- Int Psychogeriatr (1)
- J Allergy Clin Immunol (1)
- J Am Board Fam Pract (1)
- J Am Coll Dent (1)
- J Am Coll Surg (1)
- J Am Diet Assoc (3)
- J Am Med Inform Assoc (1)
- J Am Pharm Assoc (1)
- J Can Dent Assoc (2)
- J Card Fail (1)
- J Clin Eng (1)
- J Clin Pharmacol (1)
- J Drugs Dermatol (1)
- J Emerg Med (1)
- J Endod (1)
- J Environ Pathol Toxicol (1)
- J Expo Anal Environ Epidemiol (1)
- J Food Prot (1)
- J Healthc Mater Manage (1)
- J Immunol (1)
- J Neural Eng (1)
- J Neurosurg Spine (1)
- J Proteome Res (1)
- J Thorac Cardiovasc Surg (1)
- J Vasc Surg (1)
- JAMA (3)
- Lancet (3)
- Magn Reson Med (1)
- Med Device Technol (6)
- Med Law (1)
- Med World News (1)
- Medical Devices (38)
- MMWR Morb Mortal Wkly Rep (1)
- Mod Healthc (3)
- NIH (354)
- Nippon Hoshasen Gijutsu Gakkai Zasshi (1)
- NY Times (Print) (2)
- OR Manager (1)
- Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1)
- Pa Med (1)
- Pacing Clin Electrophysiol (1)
- Patient Safety (143)
- PDA J Pharm Sci Technol (1)
- Pediatrics (1)
- Public Health Rep (1)
- PubMed Medical Devices (42)
- PubMed Recall (86)
- Purch Adm (2)
- Recalls (202)
- Regulatory Affairs (32084)
- Rev Elev Med Vet Pays Trop (1)
- Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (1)
- Stud Health Technol Inform (1)
- Surg Endosc (1)
- Time (1)
- Transfus Med Rev (1)
- Transfusion (1)
- Uncategorized (4476)
- US News World Rep (1)
- Vaccine (1)
- Value Health (1)
- Women Health (1)
- Yahoo FDA News (8060)
Content Cloud
amgen application approval approved approves benefit blog bone cancer catholics cell citizen cystic device eggs fees fibrosis health industry journal marketwatch medscape merck obama press prostate questions recalls release religious reuters safety shortages skincancer states street tested therapeutics times tucson type valley wall washington